Tahoe Therapeutics
AI NativeMapping how chemistry perturbs biology to build a virtual model of the human cell. Formerly known as Vevo Therapeutics.
Est 2022|Valuation $131M|Raised $50M
Mapping how chemistry perturbs biology to build a virtual model of the human cell. Formerly known as Vevo Therapeutics.